JiangXi Tianxin Pharm Co Ltd (603235) — Capital Reinvestment Ratio
JiangXi Tianxin Pharm Co Ltd (603235) has a Capital Reinvestment Ratio of 0.92x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥629.36 Million) in capital expenditures (CN¥580.68 Million). See net asset quality index of JiangXi Tianxin Pharm Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
JiangXi Tianxin Pharm Co Ltd Capital Reinvestment Ratio (2020–2025)
This chart tracks JiangXi Tianxin Pharm Co Ltd's Capital Reinvestment Ratio across 6 annual periods. Check JiangXi Tianxin Pharm Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for JiangXi Tianxin Pharm Co Ltd (2020–2025)
Year-by-year Capital Reinvestment Ratio for JiangXi Tianxin Pharm Co Ltd from 2020 to 2025. For live market cap and broader valuation context, see 603235 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.92x | CN¥629.36 Million | CN¥580.68 Million | ▼ -56.8% |
| 2024 | 2.14x | CN¥499.66 Million | CN¥1.07 Billion | ▲ +190.7% |
| 2023 | 0.73x | CN¥729.21 Million | CN¥535.60 Million | ▲ +71.0% |
| 2022 | 0.43x | CN¥606.61 Million | CN¥260.50 Million | ▲ +63.1% |
| 2021 | 0.26x | CN¥818.63 Million | CN¥215.50 Million | ▲ +1.1% |
| 2020 | 0.26x | CN¥1.16 Billion | CN¥303.04 Million | — |